Observational studyBMC pregnancy and childbirth2025
Association between total oxytocin dose and maternal and neonatal morbidity during labour induction: a retrospective study.
Observational study in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dose-response relationship between oxytocin exposure during labor induction and neonatal hyperbilirubinemia.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOxytocin is one of the most widely used treatments in obstetrics. French guidelines favour low-dose protocols to avoid excessive uterine activity. Therefore, there is no recommendation for the maximum total dose to be administered. Several investigations exist about oxytocin dosage during spontaneous labour and induction. They have rarely reported total doses or analysed their association with maternal and neonatal factors.
methodsWe assessed the association between cumulative doses of oxytocin and maternal complications such as post-partum haemorrhage and emergency cesarean in the context of labour induction. We conducted an observational, retrospective, monocentric study in a tertiary care centre. We recruited single pregnancies with induction of labour and oxytocin administration during labour at term. The exclusion criteria were previous cesarean and foetus with identified pathology requiring immediate post-partum transfer. We recorded socio-demographic characteristics, obstetrical and neonatal data.
resultsIn all, 3598 women receiving induction of labour after 37
conclusionThis study alerts to potential morbidity at oxytocin cumulative doses of 5 IU or greater, and so more likely at 10 IU, administered during induction of labour. Obstetric considerations and decisions should be guided by the co-factors of morbidity, in particular parity and need for cervical ripening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.